CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...
Investing.com -- Stereotaxis (NYSE:STXS) stock surged 8.3% Tuesday after the surgical robotics company announced it received U.S. Food and Drug Administration (FDA) approval for its MAGiC Magnetic ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained U.S.
MedPage Today on MSN
First transcatheter coronary bypass; Y chromosome loss & MI; GLP-1s vs brain bleeds
A first-in-human percutaneous aorto-coronary bypass procedure, dubbed "VECTOR," was used to prevent coronary obstruction ...
European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Stereotaxis Inc. secured U.S. FDA approval for its Magic magnetic interventional ablation catheter, marking a key step in the ...
Dr. Peter Weiss, one of the biggest boosters of robotic magnetic navigation, offers his perspective on the needs of EPs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback